~equinox-8144
What method does Equinox Group use to quantify clinical benefit?
What is the role of Analysts at Equinox Group?
What factors determine the pricing potential of a new rare-diseases therapy?
What tools does Equinox Group have for R&D decisions?
What factors does Equinox Group consider in their measure of clinical benefit?
How can the oncology DTA models be used to estimate the price potential of new assets or regimens?
